Loading
  • Facebook
  • LinkedIn
  • Twitter
  • Instagram
  • Pinterest
  • Youtube
  • Mail
  • Rss
  • Log In
    • Register
Contacts us @ MediPr.org
Medical Writer Agency | 香港醫學作家 | MediPR | MediPaper Hong Kong
  • MDnews
  • About [‘mediPr]
  • Search
  • Menu Menu
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on Pinterest
  • Share on LinkedIn
  • Share on Tumblr
  • Share by Mail

Non-Sponsored Content


INFECTIOUS DISEASE

How do people get Covid-19 in Hong Kong?

Analyzed by: Dr Siddharth Sridhar, Specialist in Clinical Microbiology & Infection | Last updated: 20th February 2020 | In: COVID-19, Critical Care Medicine, Infectious Disease, Internal Medicine, Pneumonia, SARS-CoV2

Article Keywords

2019-nCoV, China, corona virus, COVID-19, pneumonia, WARS

中文版

Here, I look at the main settings of Covid-19 transmission in Hong Kong (as of 20/2/2020):

  1. Most Covid-19 transmission in Hong Kong is within families. Of the first 65 cases reported in HK, 27 (~ 42%) acquired the infection from a family member in a household or social setting where masks are less likely to be worn.
  2. However, 16/65 (24.6%) of patients acquired the infection from an unknown source. Some of these patients subsequently passed the infection to their family members.
  3. Imported cases only accounted for 4 of 41 cases reported since 7/2/2020.

To protect your family, please wear a mask in public areas. Avoid crowded areas and large gatherings at this time.

YOU MAY ALSO LIKE

content continues below

Evidence-of-SARS-CoV2-in-heart-cells
  • Save
22nd September 2020

Evidence of SARS-CoV2 in heart cells

triple-combination-effective-for-hospital-and-ventilator-acquired-pneumonia
  • Save
10th September 2020

Triple combination effective for hospital- and ventilator-acquired pneumonia

Dr Siddharth Sridhar - 2019-nCoV - COVID-19 - How do People get Covid-19 in Hong Kong
  • Save

Newsletter

YOU MAY ALSO LIKE

Evidence-of-SARS-CoV2-in-heart-cells
  • Save

Evidence of SARS-CoV2 in heart cells

https://medi-paper.com/wp-content/uploads/2020/09/Evidence-of-SARS-CoV2-in-heart-cells.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-09-22 10:19:272020-09-24 12:33:04Evidence of SARS-CoV2 in heart cells
triple-combination-effective-for-hospital-and-ventilator-acquired-pneumonia
  • Save

Triple combination effective for hospital- and ventilator-acquired pneumonia

https://medi-paper.com/wp-content/uploads/2020/09/triple-combination-effective-for-hospital-and-ventilator-acquired-pneumonia-scaled.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-09-10 11:04:232020-09-23 17:03:43Triple combination effective for hospital- and ventilator-acquired pneumonia
risk-of-thrombosis-with-sars-cov-2-infection
  • Save

Risk of thrombosis with SARS-CoV-2 infection

https://medi-paper.com/wp-content/uploads/2020/08/risk-of-thrombosis-with-sars-cov-2-infection-scaled.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-27 16:33:072020-09-24 12:37:30Risk of thrombosis with SARS-CoV-2 infection
no-difference-in-kidney-transplantation-outcomes-for-HIV-positive-recipients-regardless-of-donor-HIV-status
  • Save

No difference in kidney transplantation outcomes for HIV-positive recipients regardless of donor HIV status

https://medi-paper.com/wp-content/uploads/2020/08/no-difference-in-kidney-transplantation-outcomes-for-HIV-positive-recipients-regardless-of-donor-HIV-status-scaled.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-25 10:15:352020-08-25 15:48:17No difference in kidney transplantation outcomes for HIV-positive recipients regardless of donor HIV status
PreviousNext

Disclaimer

This article is not medical advice. Patients should seek personal assessment by a licenced specialist. Physicians are recommended to read the full publication(s) as cited in the article before making medical decisions. This article does not supersede nor replace the published article(s).

© Copyright 2020 Dr Sridhar Siddharth – How do people get Covid-19 in Hong Kong?

Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on Pinterest
  • Share on LinkedIn
  • Share on Tumblr
  • Share by Mail

YOU MAY ALSO LIKE

Evidence-of-SARS-CoV2-in-heart-cells
  • Save

Evidence of SARS-CoV2 in heart cells

https://medi-paper.com/wp-content/uploads/2020/09/Evidence-of-SARS-CoV2-in-heart-cells.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-09-22 10:19:272020-09-24 12:33:04Evidence of SARS-CoV2 in heart cells
triple-combination-effective-for-hospital-and-ventilator-acquired-pneumonia
  • Save

Triple combination effective for hospital- and ventilator-acquired pneumonia

https://medi-paper.com/wp-content/uploads/2020/09/triple-combination-effective-for-hospital-and-ventilator-acquired-pneumonia-scaled.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-09-10 11:04:232020-09-23 17:03:43Triple combination effective for hospital- and ventilator-acquired pneumonia
risk-of-thrombosis-with-sars-cov-2-infection
  • Save

Risk of thrombosis with SARS-CoV-2 infection

https://medi-paper.com/wp-content/uploads/2020/08/risk-of-thrombosis-with-sars-cov-2-infection-scaled.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-27 16:33:072020-09-24 12:37:30Risk of thrombosis with SARS-CoV-2 infection
no-difference-in-kidney-transplantation-outcomes-for-HIV-positive-recipients-regardless-of-donor-HIV-status
  • Save

No difference in kidney transplantation outcomes for HIV-positive recipients regardless of donor HIV status

https://medi-paper.com/wp-content/uploads/2020/08/no-difference-in-kidney-transplantation-outcomes-for-HIV-positive-recipients-regardless-of-donor-HIV-status-scaled.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-25 10:15:352020-08-25 15:48:17No difference in kidney transplantation outcomes for HIV-positive recipients regardless of donor HIV status
residual-risk-of-hepatocellular-carcinoma-in-older-hepatitis-c-patients-even-after-viral-clearance
  • Save

Residual risk of hepatocellular carcinoma in older Hepatitis C patients even after viral clearance

https://medi-paper.com/wp-content/uploads/2020/08/residual-risk-of-hepatocellular-carcinoma-in-older-hepatitis-c-patients-even-after-viral-clearance-scaled.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-13 16:18:002020-08-17 16:56:12Residual risk of hepatocellular carcinoma in older Hepatitis C patients even after viral clearance
potential-protective-effects-of-the-influenza-vaccine-on-cardiovascular-outcomes-in-high-risk-populations
  • Save

Potential protective effects of the influenza vaccine on cardiovascular outcomes in high-risk populations

https://medi-paper.com/wp-content/uploads/2020/08/potential-protective-effects-of-the-influenza-vaccine-on-cardiovascular-outcomes-in-high-risk-populations-scaled.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-13 15:28:132020-08-17 16:56:09Potential protective effects of the influenza vaccine on cardiovascular outcomes in high-risk populations
updated-human-papillomavirus-vaccination-and-testing-recommendations-from-the-american-cancer-society
  • Save

Updated human papillomavirus vaccination and testing recommendations from the American Cancer Society

https://medi-paper.com/wp-content/uploads/2020/08/updated-human-papillomavirus-vaccination-and-testing-recommendations-from-the-american-cancer-society-scaled.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-13 14:41:322020-08-25 14:37:07Updated human papillomavirus vaccination and testing recommendations from the American Cancer Society
interim-results-of-a-Phase-2b-3-trial-investigating-a-long-acting-injectable-of-cabotegravir-for-pre-exposure-prophylaxis-of-HIV
  • Save

Interim results of a Phase 2b/3 trial investigating a long-acting injectable of cabotegravir for pre-exposure prophylaxis of HIV

https://medi-paper.com/wp-content/uploads/2020/08/interim-results-of-a-Phase-2b-3-trial-investigating-a-long-acting-injectable-of-cabotegravir-for-pre-exposure-prophylaxis-of-HIV-scaled.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-04 14:44:162020-08-19 11:39:24Interim results of a Phase 2b/3 trial investigating a long-acting injectable of cabotegravir for pre-exposure prophylaxis of HIV
comparison-of-the-metabolic-changes-from-the-tango-trial-a-post-hoc-analysis
  • Save

Comparison of the metabolic changes from the TANGO trial: a post-hoc analysis

https://medi-paper.com/wp-content/uploads/2020/08/comparison-of-the-metabolic-changes-from-the-tango-trial-a-post-hoc-analysis-scaled.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-04 14:02:232020-08-19 11:39:13Comparison of the metabolic changes from the TANGO trial: a post-hoc analysis
Carboplatin plus paclitaxel to be the new standard of care for anal cancer
  • Save

Carboplatin plus paclitaxel to be the new standard of care for anal cancer

https://medi-paper.com/wp-content/uploads/2020/07/Carboplatin-plus-paclitaxel-to-be-the-new-standard-of-care-for-anal-cancer.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-07-10 17:24:482020-08-11 09:52:36Carboplatin plus paclitaxel to be the new standard of care for anal cancer
Dr Sridhar Siddharth - Clinical characteristics of patients with 2019-nCoV pneumonia COVID-19 2019-nCoV WuhanOutbreak Pneumonia
  • Save

Updated: Clinical characteristics of patients with COVID-19

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Sridhar-Siddharth-Clinical-characteristics-of-patients-with-2019-nCoV-pneumonia.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-26 15:23:392020-09-24 12:33:08Updated: Clinical characteristics of patients with COVID-19
Dr Siddharth Sridhar - 2019-nCoV COVID-19 in Hong Kong - the end of the beginning
  • Save

COVID-19 in Hong Kong: the end of the beginning?

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Siddharth-Sridhar-2019-nCoV-COVID-19-in-Hong-Kong-the-end-of-the-beginning-1-1.jpg 760 1000 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-22 13:48:352020-09-24 12:33:08COVID-19 in Hong Kong: the end of the beginning?
Dr Siddharth Sridhar - 2019-nCoV - Summary of the situation in HK 2019-nCoV在本港的概況 COVID-19 2019-nCoV WuhanOutbreak Pneumonia
  • Save

2019-nCoV – Summary of the situation in HK as of Feb 6, 2020

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Siddharth-Sridhar-2019-nCoV-Summary-of-the-situation-in-HK-2019-nCoV在本港的概況.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-07 00:31:582020-09-24 12:33:092019-nCoV – Summary of the situation in HK as of Feb 6, 2020
Dr Sridhar Siddharth - How infectious is novel coronavirus 2019 nCoV 新型冠狀病毒 2019-nCoV 的傳染性有多高 COVID-19 2019-nCoV WuhanOutbreak Pneumonia
  • Save

How infectious is novel coronavirus (2019-nCoV)

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Sridhar-Siddharth-How-infectious-is-novel-coronavirus-2019-nCoV-新型冠狀病毒-2019-nCoV-的傳染性有多高.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-03 22:33:562020-09-24 12:33:10How infectious is novel coronavirus (2019-nCoV)
Dr Siddharth Sridhar - How stable are coronaviruses in the environment? 2019-nCoV 冠狀病毒在環境中的穩定性 COVID-19 2019-nCoV WuhanOutbreak Pneumonia
  • Save

2019-nCoV: how stable are coronaviruses in the environment?

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Siddharth-Sridhar-How-stable-are-coronaviruses-in-the-environment-2019-nCoV-冠狀病毒在環境中的穩定性.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-02 19:45:432020-09-24 12:33:102019-nCoV: how stable are coronaviruses in the environment?
Dr Sridhar Siddharth - Who gets severe novel coronavirus (2019-nCoV) infection COVID-19 2019-nCoV WuhanOutbreak Pneumonia
  • Save

Who gets severe novel coronavirus (2019-nCoV) infection?

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Sridhar-Siddharth-Who-gets-severe-novel-coronavirus-2019-nCoV-infection.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-01 23:45:262020-09-24 12:33:10Who gets severe novel coronavirus (2019-nCoV) infection?
Can a novel, temporary, and fully resorbable surgical implant improve the outcome of common hockey and soccer injuries?
  • Save

Can a novel, temporary, and fully resorbable surgical implant improve the outcome of common hockey and soccer injuries?

https://medi-paper.com/wp-content/uploads/2019/04/Can-a-novel-temporary-and-fully-resorbable-surgical-implant-improve-the-outcome-of-common-hockey-and-soccer-injuries.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2019-04-26 20:05:262019-04-26 20:12:32Can a novel, temporary, and fully resorbable surgical implant improve the outcome of common hockey and soccer injuries?
FDA approved lusutrombopag (Mulpleta, Shionogi Inc.) for thrombocytopenia in adults with chronic liver disease who are scheduled to undergo a medical or dental procedure. More Information.  July 31, 2018.
  • Save

Lusutrombopag FDA approved for thrombocytopenia in adult chronic liver disease patients

https://medi-paper.com/wp-content/uploads/2018/08/FDA-approved-lusutrombopag-Mulpleta-Shionogi-Inc.-for-thrombocytopenia-in-adults-with-chronic-liver-disease-who-are-scheduled-to-undergo-a-medical-or-dental-procedure.-More-Information.-July-31-2018-e1537925382959.jpg 1000 1495 News Feed https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png News Feed2018-08-01 09:21:032018-08-12 16:46:52Lusutrombopag FDA approved for thrombocytopenia in adult chronic liver disease patients
PreviousNext
0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply Cancel reply

You must be logged in to post a comment.

© Copyright 2020 Dr Sridhar Siddharth – How do people get Covid-19 in Hong Kong?

Therapeutic Areas

Login

or
Login with Google
Login with Facebook
Login with Twitter
Login with LinkedIn
  • Register
  • Lost your password?

Or, sign up for our newsletter


Advertisement

© 2016-2020 MediPaper Medical Communications Ltd. | Website by [’mediPr] | 醫學作家香港 | Privacy Policy | Cookie Policy
  • Facebook
  • LinkedIn
  • Twitter
  • Instagram
  • Pinterest
  • Youtube
  • Mail
  • Rss
Capivasertib added to fulvestrant improves progression-free survival in advanced...
Capivasertib added to fulvestrant improves progression-free survival in advanced breast cancer patients
  • Save
Dr Siddharth Sridhar - 2019-nCoV COVID-19 in Hong Kong - the end of the beginning
  • Save
COVID-19 in Hong Kong: the end of the beginning?
Scroll to top

This site uses cookies to improve your experience. By continuing to browse the site, you are agreeing to our use of cookies.

OKPrivacy Settings

Cookies and Privacy on medi-paper.com



Cookie Policy

How MediPaper uses cookies is explained in our Cookie Policy

Privacy Policy

Read MediPaper's Privacy Policy

Google Analytics cookies

These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.

If you do not want that we track your visist to our site you can disable tracking in your browser here:

Other external services

We also use different external services like Google Webfonts, Google Maps and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Google Map Settings:

Vimeo and Youtube video embeds:

Accept settingsHide notification only
Copy link
CopyCopied
Powered by Social Snap
MediPaper Medical Communications Agency Hong Kong Blog